(A) In accordance with Chapter 119. of the Revised Code, the board of nursing shall adopt rules as necessary to implement the provisions of this chapter pertaining to the authority of advanced practice registered nurses who are designated as clinical nurse specialists, certified nurse-midwives, and certified nurse practitioners to prescribe and furnish drugs and therapeutic devices .
The board shall adopt rules that are consistent with a recommended exclusionary formulary the board receives from the committee on prescriptive governance pursuant to section 4723.492 of the Revised Code. After reviewing a formulary submitted by the committee, the board may either adopt the formulary as a rule or ask the committee to reconsider and resubmit the formulary. The board shall not adopt any rule that does not conform to a formulary developed by the committee.
The exclusionary formulary shall permit the prescribing of controlled substances, as defined in section 3719.01 of the Revised Code, in a manner consistent with section 4723.481 of the Revised Code. The formulary shall not permit the prescribing or furnishing of any of the following:
(1) A drug or device to perform or induce an abortion;
(2) A drug or device prohibited by federal or state law.
(B) In addition to the rules described in division (A) of this section, the board shall adopt rules under this section that do the following:
(2) Establish requirements for board approval of the two-hour course of instruction in the laws of this state as required under division (C)(1) of section 4723.482 of the Revised Code and division (B)(2) of section 4723.484 of the Revised Code;
(3) Establish criteria for the components of the standard care arrangements described in section 4723.431 of the Revised Code that apply to the authority to prescribe, including the components that apply to the authority to prescribe schedule II controlled substances. The rules shall be consistent with that section and include all of the following:
(a) Quality assurance standards;
(b) Standards for periodic review by a collaborating physician or podiatrist of the records of patients treated by the clinical nurse specialist, certified nurse-midwife, or certified nurse practitioner;
(c) Acceptable travel time between the location at which the clinical nurse specialist, certified nurse-midwife, or certified nurse practitioner is engaging in the prescribing components of the nurse's practice and the location of the nurse's collaborating physician or podiatrist;
(d) Any other criteria recommended by the committee on prescriptive governance.
Amended by 131st General Assembly File No. TBD, HB 216, §1, eff. 4/6/2017.
Amended by 131st General Assembly File No. TBD, HB 64, §101.01, eff. 9/29/2015.
Amended by 131st General Assembly File No. TBD, SB 110, §1, eff. 10/15/2015.
Amended by 129th General AssemblyFile No.194, HB 303, §1, eff. 3/20/2013.
Amended by 129th General AssemblyFile No.85, SB 83, §1, eff. 6/8/2012.
Amended by 128th General AssemblyFile No.14, SB 89, §1, eff. 3/29/2010.
Effective Date: 05-17-2000; 05-17-2006
Related Legislative Provision: See 129th General AssemblyFile No.85, SB 83, §4 .
See 129th General AssemblyFile No.85, SB 83, §3 .